Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.01 (+0.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) EV to EBITDA (2025)

Updated

Black Diamond Therapeutics' (BDTX) EV to EBITDA was 0.79 for Q4 2025, down 87.9% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) EV to EBITDA (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.79
Sep 30, 2025 6.58
Jun 30, 2025 -0.35
API Access

Black Diamond Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BDTX&period=max&api_key=YOUR_API_KEY